Nanobiotix Raises $71 Million in Royalty Monetization Deal with HealthCare Royalty to Boost Oncology Pipeline

Nanobiotix has entered a $71 million royalty monetization deal with HealthCare Royalty, unlocking the value of its intellectual property while retaining ownership. This rare and strategic move provides financial flexibility and supports future growth. The partnership highlights how patent monetization can drive collaboration, innovation, and long-term success in today’s competitive business landscape.

https://patentmonetize.com/nan....obiotix-royalty-mone

What to Do After Receiving a Patent Infringement or Licensing Notice

Patent licensing is a key method of monetization in India, but it can also lead to licensing or infringement notices. When such issues arise, it’s important to stay calm and respond strategically. Understanding the right steps to take can help protect your business from legal risks and financial losses while ensuring compliance.

https://patentmonetize.com/res....ponse-of-patent-lice

MGI Tech Signs Exclusive Licensing Agreement with Swiss Rockets AG for CoolMPS™ Sequencing Technology

MGI Tech Co., Ltd. and Swiss Rockets AG have signed an exclusive licensing agreement to expand access to MGI’s CoolMPS sequencing technology. This partnership strengthens MGI’s global presence, accelerates genomics research, and positions Swiss Rockets as a key player in advancing next-generation sequencing and precision medicine worldwide.

https://patentmonetize.com/mgi....-tech-and-swiss-rock

Nokia Signs Patent Licensing Deal with Starz to Expand Streaming Technology Portfolio

Nokia has signed a new patent licensing agreement with U.S.-based streaming provider Starz, marking a major step in expanding its global multimedia and video streaming patent portfolio. This deal strengthens Nokia’s position as a leader in patent licensing and showcases its growing influence in digital entertainment and streaming technology innovation worldwide.

https://patentmonetize.com/nok....ia-patent-licensing-

T-Booster Capsules – 100% Ayurvedic Testosterone Booster for Men

Step into a healthier, more confident version of yourself with Khalas T-Booster Capsules. Designed for today’s men, this herbal formulation combines 100% Ayurvedic ingredients to naturally boost testosterone, increase stamina, and support overall vitality – all without side effects.
Each capsule blends ancient wisdom with modern trust, giving you the strength to perform at your best. At Khalas Ayurveda, we make herbal wellness a household name by delivering solutions that are safe, effective, and reliable. Choose nature’s wisdom, rediscover your strength, and experience lasting confidence today.

#tboostercapsules #ayurvedictestosteronebooster

https://khalasayurveda.in/prod....uct/t-booster-capsul

What We Do After Patent Monetization for Long-Term Success?

The process After monetizing a patent, the next step is to strategically manage and grow its value. Reinvest the revenue in new research, expand your patent portfolio, and monitor market trends. Maintain strong relationships with partners and plan a long-term IP strategy. This phase ensures continuous innovation and turns one success into sustained business growth.

https://patentmonetize.com/pro....cess-after-patent-mo

De Addiction Drug | Ayurvedic Nasha Mukti Medicine

Take charge of your health with Khalas Ayurveda’s GIO Tablets, a trusted De Addiction Drug | Ayurvedic Nasha Mukti Medicine. Made from 100% herbal ingredients, it naturally detoxifies the body, reduces cravings, and restores mental and physical balance safely.
Designed to support men and women on their journey to recovery, GIO Tablets combine centuries of Ayurvedic wisdom with modern quality standards for reliable, effective results. Make Khalas Ayurveda your partner in wellness and take the first step toward a stronger, addiction-free life. Reclaim your confidence, embrace freedom, and experience the power of nature-backed recovery today.

https://khalasayurveda.in/prod....uct/de-addiction-dru

Global Gamma-Butyrolactone (GBL) market is projected to expand from USD 1.2 Billion in 2024 to approximately USD 1.8 Billion by 2030, reflecting a CAGR of 5.8%

Global Gamma-Butyrolactone (GBL) market is expanding, driven by its vital role as a solvent and precursor in the pharmaceutical, electronics (batteries), and agrochemical sectors. Key challenges include raw material price volatility and strict regulatory controls due to potential misuse. Asia-Pacific remains the dominant region.

Read our full Report: : https://www.24chemicalresearch.....com/reports/274320/